About BenevolentAI
BenevolentAI is a drug discovery company that uses AI and machine learning to accelerate the discovery and development of new medicines for complex diseases.
Mission & Story
Mission
We build technology in the service of science
Founding Story
Recognised early on that every data point holds the potential for ground-breaking discoveries, building on a decade of investment in knowledge graph and proprietary ontologies
Who It Serves
Milestones & Awards
Awards & Recognition
Described as a pioneer in AI drug discovery
Social & Media
Follow on
Latest Updates
Blog01 Jul 2024CSO, Anne Phelan talks to Emerj about the challenges of drug discovery and how AI can be used to tackle thisRead more
Video20 Apr 2023BenevolentAI’s approach to AI-enabled drug discoveryRead more
Video11 Jan 2024Dr Francois Nader • 42nd Annual J.P. Morgan Healthcare ConferenceRead more
Blog27 Apr 2023BenevolentAI’s CSO, Anne Phelan, recognised for her contributions to innovation in drug developmentRead more
Blog03 May 2023Sano Genetics & BenevolentAI: Combining machine learning with genetic and medical data in ulcerative colitisRead more
Company Details
- Founded
- 2013
- Headquarters
- London, UK
- Employees
- 180
- Stage
- public
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSimilar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Clario
Clario provides digital endpoint technology and evidence generation solutions for clinical trials. The company offers cardiac safety, eCOA, medical imaging, precision motion, and respiratory solutions to pharmaceutical, biotech, and CRO clients across all trial phases.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.